| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | antigen binding | 6.73e-07 | 190 | 53 | 7 | GO:0003823 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 1.66e-05 | 19 | 53 | 3 | GO:0032794 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 6.88e-05 | 5 | 53 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | C-X3-C chemokine binding | 6.88e-05 | 5 | 53 | 2 | GO:0019960 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.29e-04 | 37 | 53 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 1.44e-04 | 7 | 53 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.82e-04 | 775 | 53 | 9 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.29e-04 | 839 | 53 | 9 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.32e-04 | 840 | 53 | 9 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.32e-04 | 840 | 53 | 9 | GO:0016818 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.59e-04 | 127 | 53 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 5.24e-04 | 709 | 53 | 8 | GO:0016773 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.42e-04 | 262 | 53 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 7.37e-04 | 938 | 53 | 9 | GO:0016772 | |
| GeneOntologyMolecularFunction | helicase activity | 8.17e-04 | 158 | 53 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | kinase activity | 8.54e-04 | 764 | 53 | 8 | GO:0016301 | |
| GeneOntologyMolecularFunction | protein kinase activity | 9.92e-04 | 600 | 53 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 1.69e-03 | 23 | 53 | 2 | GO:0016004 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 1.99e-03 | 25 | 53 | 2 | GO:0031683 | |
| GeneOntologyMolecularFunction | GTPase activity | 2.07e-03 | 341 | 53 | 5 | GO:0003924 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.12e-03 | 343 | 53 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 2.18e-03 | 97 | 53 | 3 | GO:0004896 | |
| GeneOntologyMolecularFunction | lipase activator activity | 2.33e-03 | 27 | 53 | 2 | GO:0060229 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 2.50e-03 | 28 | 53 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.71e-03 | 363 | 53 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | chemokine binding | 3.46e-03 | 33 | 53 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | GTP binding | 3.97e-03 | 397 | 53 | 5 | GO:0005525 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.88e-03 | 129 | 53 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 4.98e-03 | 130 | 53 | 3 | GO:0005200 | |
| GeneOntologyMolecularFunction | histone binding | 5.33e-03 | 265 | 53 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 5.82e-03 | 43 | 53 | 2 | GO:0043548 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 6.06e-03 | 439 | 53 | 5 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 6.06e-03 | 439 | 53 | 5 | GO:0019001 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 6.47e-03 | 446 | 53 | 5 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 6.74e-03 | 145 | 53 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 7.28e-03 | 459 | 53 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 7.53e-03 | 151 | 53 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 7.67e-03 | 152 | 53 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.68e-03 | 465 | 53 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | growth factor binding | 8.23e-03 | 156 | 53 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | cytokine binding | 8.38e-03 | 157 | 53 | 3 | GO:0019955 | |
| GeneOntologyMolecularFunction | immune receptor activity | 9.59e-03 | 165 | 53 | 3 | GO:0140375 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IL7R IGLV3-25 IGLV3-19 IGLV3-16 | 1.08e-13 | 241 | 58 | 13 | GO:0002377 |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IL7R IGLV3-25 IGLV3-19 IGLV3-16 | 7.10e-11 | 403 | 58 | 13 | GO:0002440 |
| GeneOntologyBiologicalProcess | adaptive immune response | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 CX3CR1 IGLV3-27 IL7R IGLV3-25 MASP2 IGLV3-19 IGLV3-16 | 6.96e-09 | 838 | 58 | 15 | GO:0002250 |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 7.23e-05 | 79 | 58 | 4 | GO:0072577 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 IGLV3-16 | 2.74e-14 | 166 | 58 | 12 | GO:0019814 |
| GeneOntologyCellularComponent | CHD-type complex | 1.34e-05 | 17 | 58 | 3 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 1.34e-05 | 17 | 58 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 9.14e-05 | 85 | 58 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.47e-04 | 96 | 58 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | cell body | CACNA1D PTPN13 KCNB1 TRPM7 ACAN PDPK1 TUBB KCNB2 CX3CR1 NRP1 | 2.14e-04 | 929 | 58 | 10 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body membrane | 2.31e-04 | 43 | 58 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 3.01e-04 | 47 | 58 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | ATPase complex | 4.54e-04 | 129 | 58 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | centrosome | 1.23e-03 | 770 | 58 | 8 | GO:0005813 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 2.01e-03 | 24 | 58 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | neuronal cell body | 2.05e-03 | 835 | 58 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | intercellular bridge | 2.27e-03 | 94 | 58 | 3 | GO:0045171 | |
| GeneOntologyCellularComponent | cell leading edge | 2.57e-03 | 500 | 58 | 6 | GO:0031252 | |
| GeneOntologyCellularComponent | side of membrane | 2.74e-03 | 875 | 58 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.75e-03 | 210 | 58 | 4 | GO:0031256 | |
| GeneOntologyCellularComponent | heterochromatin | 2.79e-03 | 101 | 58 | 3 | GO:0000792 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 3.09e-03 | 519 | 58 | 6 | GO:0009897 | |
| GeneOntologyCellularComponent | cell surface | 3.33e-03 | 1111 | 58 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | perikaryon | 3.41e-03 | 223 | 58 | 4 | GO:0043204 | |
| GeneOntologyCellularComponent | microtubule organizing center | 3.69e-03 | 919 | 58 | 8 | GO:0005815 | |
| Domain | CHDCT2 | 1.22e-08 | 3 | 44 | 3 | PF08074 | |
| Domain | CHDNT | 1.22e-08 | 3 | 44 | 3 | PF08073 | |
| Domain | DUF1086 | 1.22e-08 | 3 | 44 | 3 | IPR009462 | |
| Domain | DUF1087 | 1.22e-08 | 3 | 44 | 3 | IPR009463 | |
| Domain | CHD_N | 1.22e-08 | 3 | 44 | 3 | IPR012958 | |
| Domain | CHD_C2 | 1.22e-08 | 3 | 44 | 3 | IPR012957 | |
| Domain | DUF1087 | 1.22e-08 | 3 | 44 | 3 | PF06465 | |
| Domain | DUF1086 | 1.22e-08 | 3 | 44 | 3 | PF06461 | |
| Domain | DUF1087 | 1.22e-08 | 3 | 44 | 3 | SM01147 | |
| Domain | DUF1086 | 1.22e-08 | 3 | 44 | 3 | SM01146 | |
| Domain | K_chnl_volt-dep_Kv2 | 5.42e-06 | 2 | 44 | 2 | IPR003973 | |
| Domain | Kv2channel | 5.42e-06 | 2 | 44 | 2 | PF03521 | |
| Domain | Ion_trans_dom | 6.97e-06 | 114 | 44 | 5 | IPR005821 | |
| Domain | Ion_trans | 6.97e-06 | 114 | 44 | 5 | PF00520 | |
| Domain | Chromo_domain | 2.39e-05 | 24 | 44 | 3 | IPR023780 | |
| Domain | PHD | 2.88e-05 | 75 | 44 | 4 | PF00628 | |
| Domain | Chromo | 3.05e-05 | 26 | 44 | 3 | PF00385 | |
| Domain | CHROMO_1 | 3.84e-05 | 28 | 44 | 3 | PS00598 | |
| Domain | CHROMO_2 | 3.84e-05 | 28 | 44 | 3 | PS50013 | |
| Domain | PHD | 5.65e-05 | 89 | 44 | 4 | SM00249 | |
| Domain | SNF2_N | 5.77e-05 | 32 | 44 | 3 | IPR000330 | |
| Domain | Chromodomain-like | 5.77e-05 | 32 | 44 | 3 | IPR016197 | |
| Domain | SNF2_N | 5.77e-05 | 32 | 44 | 3 | PF00176 | |
| Domain | Znf_PHD | 6.17e-05 | 91 | 44 | 4 | IPR001965 | |
| Domain | Chromo/shadow_dom | 6.33e-05 | 33 | 44 | 3 | IPR000953 | |
| Domain | CHROMO | 6.33e-05 | 33 | 44 | 3 | SM00298 | |
| Domain | ZF_PHD_2 | 7.30e-05 | 95 | 44 | 4 | PS50016 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 7.57e-05 | 35 | 44 | 3 | IPR002464 | |
| Domain | ZF_PHD_1 | 7.60e-05 | 96 | 44 | 4 | PS01359 | |
| Domain | DEAH_ATP_HELICASE | 9.71e-05 | 38 | 44 | 3 | PS00690 | |
| Domain | Gprotein_alpha_I | 1.51e-04 | 8 | 44 | 2 | IPR001408 | |
| Domain | CUB | 2.08e-04 | 49 | 44 | 3 | PF00431 | |
| Domain | CUB | 2.21e-04 | 50 | 44 | 3 | SM00042 | |
| Domain | Beta-tubulin_BS | 2.41e-04 | 10 | 44 | 2 | IPR013838 | |
| Domain | Beta_tubulin | 2.41e-04 | 10 | 44 | 2 | IPR002453 | |
| Domain | - | 2.49e-04 | 52 | 44 | 3 | 2.60.120.290 | |
| Domain | Kinase-like_dom | 2.52e-04 | 542 | 44 | 7 | IPR011009 | |
| Domain | CUB | 2.63e-04 | 53 | 44 | 3 | PS01180 | |
| Domain | TUBULIN_B_AUTOREG | 2.94e-04 | 11 | 44 | 2 | PS00228 | |
| Domain | CUB_dom | 3.27e-04 | 57 | 44 | 3 | IPR000859 | |
| Domain | Znf_FYVE_PHD | 3.92e-04 | 147 | 44 | 4 | IPR011011 | |
| Domain | HMG_box_dom | 4.81e-04 | 65 | 44 | 3 | IPR009071 | |
| Domain | Zinc_finger_PHD-type_CS | 4.81e-04 | 65 | 44 | 3 | IPR019786 | |
| Domain | G-alpha | 6.37e-04 | 16 | 44 | 2 | PF00503 | |
| Domain | GproteinA_insert | 6.37e-04 | 16 | 44 | 2 | IPR011025 | |
| Domain | - | 6.37e-04 | 16 | 44 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 6.37e-04 | 16 | 44 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 7.21e-04 | 17 | 44 | 2 | IPR001019 | |
| Domain | P-loop_NTPase | 7.23e-04 | 848 | 44 | 8 | IPR027417 | |
| Domain | Znf_PHD-finger | 8.51e-04 | 79 | 44 | 3 | IPR019787 | |
| Domain | - | 1.00e-03 | 20 | 44 | 2 | 3.30.1330.20 | |
| Domain | - | 1.11e-03 | 21 | 44 | 2 | 1.10.287.600 | |
| Domain | Tubulin_C | 1.22e-03 | 22 | 44 | 2 | SM00865 | |
| Domain | Tubulin_C | 1.22e-03 | 22 | 44 | 2 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.22e-03 | 22 | 44 | 2 | IPR018316 | |
| Domain | - | 1.22e-03 | 22 | 44 | 2 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.33e-03 | 23 | 44 | 2 | IPR023123 | |
| Domain | Pentatricopeptide_repeat | 1.33e-03 | 23 | 44 | 2 | IPR002885 | |
| Domain | TUBULIN | 1.33e-03 | 23 | 44 | 2 | PS00227 | |
| Domain | Tubulin | 1.33e-03 | 23 | 44 | 2 | IPR000217 | |
| Domain | Tub_FtsZ_C | 1.33e-03 | 23 | 44 | 2 | IPR008280 | |
| Domain | Tubulin | 1.33e-03 | 23 | 44 | 2 | SM00864 | |
| Domain | Tubulin_CS | 1.33e-03 | 23 | 44 | 2 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.45e-03 | 24 | 44 | 2 | IPR003008 | |
| Domain | Tubulin | 1.45e-03 | 24 | 44 | 2 | PF00091 | |
| Domain | - | 1.66e-03 | 746 | 44 | 7 | 3.40.50.300 | |
| Domain | K_chnl_volt-dep_Kv | 1.83e-03 | 27 | 44 | 2 | IPR003968 | |
| Domain | Protein_kinase_ATP_BS | 1.90e-03 | 379 | 44 | 5 | IPR017441 | |
| Domain | Helicase_C | 2.04e-03 | 107 | 44 | 3 | PF00271 | |
| Domain | HELICc | 2.04e-03 | 107 | 44 | 3 | SM00490 | |
| Domain | Helicase_C | 2.10e-03 | 108 | 44 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.15e-03 | 109 | 44 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.15e-03 | 109 | 44 | 3 | PS51192 | |
| Domain | DEXDc | 2.15e-03 | 109 | 44 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.21e-03 | 110 | 44 | 3 | IPR014001 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | IGLV2-8 EED IGLV1-44 IGLV1-40 SUPT4H1 TUBB8 PDPK1 TUBB GNAI1 CHD3 CHD4 GNAI3 TUBB8B CX3CR1 IGLV3-27 IGLV3-25 MASP2 IGLV3-19 NRP1 | 3.12e-10 | 1081 | 46 | 19 | M27548 |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | IGLV2-8 EED IGLV1-44 IGLV1-40 SUPT4H1 TUBB8 PDPK1 TUBB CHD3 CHD4 TUBB8B CX3CR1 IGLV3-27 IGLV3-25 MASP2 IGLV3-19 NRP1 | 1.03e-09 | 888 | 46 | 17 | M48034 |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | IGLV2-8 IGLV1-44 IGLV1-40 TUBB CHD3 CHD4 IGLV3-27 IGLV3-25 IGLV3-19 | 1.37e-09 | 154 | 46 | 9 | M39007 |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 2.78e-09 | 71 | 46 | 7 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 2.78e-09 | 71 | 46 | 7 | M27203 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 6.50e-09 | 80 | 46 | 7 | M6121 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | IGLV2-8 IGLV1-44 IGLV1-40 GNAI1 GNAI3 IGLV3-27 IGLV3-25 IGLV3-19 | 1.04e-08 | 134 | 46 | 8 | M29840 |
| Pathway | REACTOME_SARS_COV_INFECTIONS | IGLV2-8 IGLV1-44 IGLV1-40 PDPK1 TUBB CHD3 CHD4 IGLV3-27 IGLV3-25 MASP2 IGLV3-19 NRP1 | 2.33e-08 | 471 | 46 | 12 | M39009 |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 4.18e-08 | 61 | 46 | 6 | M27581 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 8.23e-08 | 115 | 46 | 7 | M19752 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 8.84e-08 | 69 | 46 | 6 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 8.84e-08 | 69 | 46 | 6 | M27150 | |
| Pathway | REACTOME_HEMOSTASIS | IGLV2-8 IGLV1-44 IGLV1-40 TUBB8 PDPK1 TRPC3 GNAI1 GNAI3 ITGB3 TUBB8B IGLV3-27 IGLV3-25 IGLV3-19 | 1.56e-07 | 679 | 46 | 13 | M8395 |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 2.50e-07 | 82 | 46 | 6 | M27110 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 2.61e-07 | 136 | 46 | 7 | M27207 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 3.33e-07 | 86 | 46 | 6 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 3.33e-07 | 86 | 46 | 6 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 3.57e-07 | 87 | 46 | 6 | M27205 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | IGLV2-8 IGLV1-44 IGLV1-40 GNAI1 GNAI3 IGLV3-27 IGLV3-25 IGLV3-19 | 4.69e-07 | 219 | 46 | 8 | M29836 |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 6.02e-07 | 95 | 46 | 6 | M29842 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 7.24e-07 | 98 | 46 | 6 | M27152 | |
| Pathway | REACTOME_PARASITE_INFECTION | 1.95e-06 | 116 | 46 | 6 | M29843 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 2.15e-06 | 186 | 46 | 7 | M27175 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.85e-06 | 194 | 46 | 7 | M16312 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 6.58e-06 | 143 | 46 | 6 | M27107 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.54e-05 | 166 | 46 | 6 | M608 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.14e-05 | 17 | 46 | 3 | M47544 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.31e-05 | 190 | 46 | 6 | M8240 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 4.15e-05 | 21 | 46 | 3 | M103 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 1.12e-04 | 29 | 46 | 3 | M55 | |
| Pathway | KEGG_GAP_JUNCTION | 2.07e-04 | 90 | 46 | 4 | M4013 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 2.34e-04 | 37 | 46 | 3 | M42558 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.88e-04 | 8 | 46 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.88e-04 | 8 | 46 | 2 | M47643 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.41e-04 | 411 | 46 | 7 | M735 | |
| Pathway | PID_CXCR3_PATHWAY | 3.66e-04 | 43 | 46 | 3 | M222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 3.70e-04 | 9 | 46 | 2 | M47641 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | IGLV2-8 IGLV1-44 IGLV1-40 TUBB8 TUBB8B IGLV3-27 IL7R IGLV3-25 IGLV3-19 | 4.75e-04 | 725 | 46 | 9 | M27507 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.23e-04 | 205 | 46 | 5 | M752 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 5.62e-04 | 11 | 46 | 2 | M47797 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.38e-04 | 121 | 46 | 4 | M872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 6.73e-04 | 12 | 46 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 6.73e-04 | 12 | 46 | 2 | M47559 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | IGLV2-8 IGLV1-44 IGLV1-40 PDPK1 TUBB ARHGAP45 MUC6 IGLV3-27 IGLV3-25 MASP2 IGLV3-19 | 8.03e-04 | 1128 | 46 | 11 | M1036 |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.25e-04 | 14 | 46 | 2 | MM14669 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 9.25e-04 | 14 | 46 | 2 | M64 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.25e-04 | 14 | 46 | 2 | M750 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.03e-03 | 61 | 46 | 3 | MM15071 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.03e-03 | 61 | 46 | 3 | M27811 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | IGLV2-8 IGLV1-44 IGLV1-40 TUBB8 PDPK1 TUBB8B IGLV3-27 IGLV3-25 IGLV3-19 | 1.23e-03 | 828 | 46 | 9 | M1058 |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 1.29e-03 | 66 | 46 | 3 | M39684 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.32e-03 | 147 | 46 | 4 | MM15854 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.37e-03 | 17 | 46 | 2 | M47768 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 1.44e-03 | 257 | 46 | 5 | MM15454 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.46e-03 | 151 | 46 | 4 | M39329 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.54e-03 | 18 | 46 | 2 | M47753 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 1.54e-03 | 261 | 46 | 5 | M1077 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.59e-03 | 71 | 46 | 3 | MM15590 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.66e-03 | 72 | 46 | 3 | MM14631 | |
| Pathway | WP_AXON_GUIDANCE | 1.66e-03 | 72 | 46 | 3 | M48335 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.72e-03 | 19 | 46 | 2 | MM15113 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.72e-03 | 19 | 46 | 2 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.72e-03 | 19 | 46 | 2 | M47813 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.79e-03 | 270 | 46 | 5 | M15514 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.85e-03 | 272 | 46 | 5 | M29619 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.86e-03 | 75 | 46 | 3 | M27874 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.91e-03 | 20 | 46 | 2 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.91e-03 | 20 | 46 | 2 | M47911 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.08e-03 | 78 | 46 | 3 | M1921 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.10e-03 | 21 | 46 | 2 | M878 | |
| Pathway | PID_S1P_META_PATHWAY | 2.10e-03 | 21 | 46 | 2 | M155 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 2.10e-03 | 21 | 46 | 2 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.10e-03 | 21 | 46 | 2 | M47767 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.31e-03 | 22 | 46 | 2 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.31e-03 | 22 | 46 | 2 | M841 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 2.31e-03 | 22 | 46 | 2 | M47903 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.49e-03 | 175 | 46 | 4 | MM14941 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 2.52e-03 | 23 | 46 | 2 | MM15952 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 2.52e-03 | 23 | 46 | 2 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.52e-03 | 23 | 46 | 2 | M47900 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.66e-03 | 85 | 46 | 3 | M3578 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 2.75e-03 | 24 | 46 | 2 | M268 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.75e-03 | 24 | 46 | 2 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.75e-03 | 24 | 46 | 2 | M47700 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 2.85e-03 | 87 | 46 | 3 | M6856 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 2.98e-03 | 25 | 46 | 2 | M39384 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.98e-03 | 25 | 46 | 2 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.98e-03 | 25 | 46 | 2 | M47710 | |
| Pathway | PID_VEGFR1_PATHWAY | 3.22e-03 | 26 | 46 | 2 | M226 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.22e-03 | 26 | 46 | 2 | M47553 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.22e-03 | 26 | 46 | 2 | M47672 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 3.40e-03 | 313 | 46 | 5 | M27867 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 3.47e-03 | 27 | 46 | 2 | MM15537 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.47e-03 | 27 | 46 | 2 | M47519 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 3.47e-03 | 27 | 46 | 2 | M760 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.54e-03 | 94 | 46 | 3 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.65e-03 | 95 | 46 | 3 | M6729 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.73e-03 | 28 | 46 | 2 | M47898 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.73e-03 | 28 | 46 | 2 | MM14943 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 3.73e-03 | 28 | 46 | 2 | MM14958 | |
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 IGLV3-16 | 4.76e-19 | 109 | 59 | 12 | 9074928 |
| Pubmed | IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-16 | 3.31e-17 | 43 | 59 | 9 | 1249422 | |
| Pubmed | IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-16 | 7.95e-17 | 47 | 59 | 9 | 814163 | |
| Pubmed | IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-16 | 9.78e-17 | 48 | 59 | 9 | 11955599 | |
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-36 IGLV8-61 IGLV4-60 IGLV3-25 IGLV3-16 | 1.79e-14 | 49 | 59 | 8 | 8951372 |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 31663850 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 5.86e-07 | 288 | 59 | 7 | 31501420 | |
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 2.08e-06 | 15 | 59 | 3 | 35695185 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 2.83e-06 | 2 | 59 | 2 | 7560064 | |
| Pubmed | Ask1 regulates murine platelet granule secretion, thromboxane A2 generation, and thrombus formation. | 2.83e-06 | 2 | 59 | 2 | 28028021 | |
| Pubmed | Kv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human β-Cell Dysfunction. | 2.83e-06 | 2 | 59 | 2 | 28607108 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29403353 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 7575689 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30091655 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24954893 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33754034 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 22508930 | ||
| Pubmed | The human genome encodes at least three non-allellic G proteins with alpha i-type subunits. | 2.83e-06 | 2 | 59 | 2 | 2440724 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 32747526 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26538660 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 2.83e-06 | 2 | 59 | 2 | 35568926 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 2.83e-06 | 2 | 59 | 2 | 8843877 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19855004 | ||
| Pubmed | 3.10e-06 | 17 | 59 | 3 | 27806305 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.22e-06 | 533 | 59 | 8 | 30554943 | |
| Pubmed | 7.23e-06 | 157 | 59 | 5 | 30186101 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 16962188 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 23161216 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 8670833 | ||
| Pubmed | Reciprocal negative regulation of PDK1 and ASK1 signaling by direct interaction and phosphorylation. | 8.48e-06 | 3 | 59 | 2 | 19920149 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 19273628 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 35072209 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 33859199 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 29342363 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 17540845 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 26159543 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 32658897 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 30836096 | ||
| Pubmed | Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus. | 8.48e-06 | 3 | 59 | 2 | 29507199 | |
| Pubmed | Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle. | 8.48e-06 | 3 | 59 | 2 | 22422395 | |
| Pubmed | In vivo analysis of dendritic cell development and homeostasis. | 8.48e-06 | 3 | 59 | 2 | 19286519 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 8626678 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 18184863 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 15788486 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 17484771 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 8504751 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 26852660 | ||
| Pubmed | Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis. | 8.48e-06 | 3 | 59 | 2 | 30279732 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 17635935 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 27248172 | ||
| Pubmed | Flt3 signaling-dependent dendritic cells protect against atherosclerosis. | 1.69e-05 | 4 | 59 | 2 | 22078798 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 12379657 | ||
| Pubmed | Guanine nucleotide-binding regulatory proteins in retinal pigment epithelial cells. | 1.69e-05 | 4 | 59 | 2 | 1902575 | |
| Pubmed | Analysis of RGSZ1 protein interaction with Galphai subunits. | 1.69e-05 | 4 | 59 | 2 | 15488169 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 22566504 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 16574654 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 10364213 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 38335058 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 9326634 | ||
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 1.69e-05 | 4 | 59 | 2 | 11248120 | |
| Pubmed | Gαi1/3 mediate Netrin-1-CD146-activated signaling and angiogenesis. | 1.69e-05 | 4 | 59 | 2 | 37153740 | |
| Pubmed | RGS10 is a selective activator of G alpha i GTPase activity. | 1.69e-05 | 4 | 59 | 2 | 8774883 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 11771389 | ||
| Pubmed | Selective thymus settling regulated by cytokine and chemokine receptors. | 1.69e-05 | 4 | 59 | 2 | 17277104 | |
| Pubmed | Gαi1 and Gαi3 regulate macrophage polarization by forming a complex containing CD14 and Gab1. | 1.69e-05 | 4 | 59 | 2 | 25825741 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 11168387 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 30012696 | ||
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 1.69e-05 | 4 | 59 | 2 | 18832081 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 21931697 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 28145731 | ||
| Pubmed | GIV/Girdin activates Gαi and inhibits Gαs via the same motif. | 1.69e-05 | 4 | 59 | 2 | 27621449 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.13e-05 | 332 | 59 | 6 | 32786267 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 34137443 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 19074135 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 12860983 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 19837659 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 26373672 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 16298104 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 12297512 | ||
| Pubmed | Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. | 2.82e-05 | 5 | 59 | 2 | 2820999 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 25242222 | ||
| Pubmed | Leukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses. | 2.82e-05 | 5 | 59 | 2 | 26903243 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 23086480 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 22230296 | ||
| Pubmed | Intestinal lamina propria dendritic cell subsets have different origin and functions. | 2.82e-05 | 5 | 59 | 2 | 19733097 | |
| Pubmed | Coupling of dopamine receptor subtypes to multiple and diverse G proteins. | 2.82e-05 | 5 | 59 | 2 | 10978845 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 24789099 | ||
| Pubmed | Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. | 2.82e-05 | 5 | 59 | 2 | 22706085 | |
| Pubmed | K+ current diversity is produced by an extended gene family conserved in Drosophila and mouse. | 2.82e-05 | 5 | 59 | 2 | 2333511 | |
| Pubmed | Regulation of the Flt3 Gene in Haematopoietic Stem and Early Progenitor Cells. | 2.82e-05 | 5 | 59 | 2 | 26382271 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 11387333 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 24415754 | ||
| Pubmed | Identification of the BRD1 interaction network and its impact on mental disorder risk. | 2.92e-05 | 35 | 59 | 3 | 27142060 | |
| Pubmed | 3.75e-05 | 38 | 59 | 3 | 33283408 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.75e-05 | 38 | 59 | 3 | 30786075 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 27166946 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 23125415 | ||
| Pubmed | Identification of the platelet ADP receptor targeted by antithrombotic drugs. | 4.23e-05 | 6 | 59 | 2 | 11196645 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 16371464 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 24516120 | ||
| Interaction | MAP2K3 interactions | 3.55e-06 | 251 | 52 | 7 | int:MAP2K3 | |
| Interaction | CDK2AP2 interactions | 7.66e-06 | 49 | 52 | 4 | int:CDK2AP2 | |
| Interaction | API5 interactions | 8.67e-06 | 188 | 52 | 6 | int:API5 | |
| Interaction | SUPT5H interactions | 9.10e-06 | 408 | 52 | 8 | int:SUPT5H | |
| Interaction | MDN1 interactions | 1.10e-05 | 196 | 52 | 6 | int:MDN1 | |
| Interaction | YWHAG interactions | CEP350 STOX2 EED PTPN13 TRPM7 SUPT4H1 PDPK1 TUBB SLAIN1 PFKFB4 PDCD4 IL7R MAP3K5 | 1.21e-05 | 1248 | 52 | 13 | int:YWHAG |
| Interaction | SMARCA2 interactions | 2.85e-05 | 346 | 52 | 7 | int:SMARCA2 | |
| Interaction | NCL interactions | 3.13e-05 | 798 | 52 | 10 | int:NCL | |
| Interaction | CACNA1D interactions | 3.16e-05 | 24 | 52 | 3 | int:CACNA1D | |
| Interaction | PWWP2A interactions | 4.41e-05 | 76 | 52 | 4 | int:PWWP2A | |
| Interaction | CBL interactions | 4.89e-05 | 516 | 52 | 8 | int:CBL | |
| Interaction | CHAF1B interactions | 5.37e-05 | 158 | 52 | 5 | int:CHAF1B | |
| Interaction | MTNR1A interactions | 6.79e-05 | 166 | 52 | 5 | int:MTNR1A | |
| Interaction | TUBB4B interactions | 8.67e-05 | 560 | 52 | 8 | int:TUBB4B | |
| Interaction | SNU13 interactions | 8.95e-05 | 285 | 52 | 6 | int:SNU13 | |
| Interaction | YAP1 interactions | PTPN13 RUVBL1 TUBB8 MYO3B TUBB GNAI1 CHD4 GNAI3 ARHGAP45 PLOD2 TUBB8B | 8.95e-05 | 1095 | 52 | 11 | int:YAP1 |
| Interaction | YWHAH interactions | CEP350 STOX2 PTPN13 TRPM7 SUPT4H1 PDPK1 SLAIN1 GNAI3 PFKFB4 PDCD4 MAP3K5 | 9.48e-05 | 1102 | 52 | 11 | int:YWHAH |
| Interaction | LIN37 interactions | 9.71e-05 | 93 | 52 | 4 | int:LIN37 | |
| Interaction | USP9X interactions | 9.97e-05 | 422 | 52 | 7 | int:USP9X | |
| Interaction | CLIP1 interactions | 1.08e-04 | 183 | 52 | 5 | int:CLIP1 | |
| Interaction | YWHAQ interactions | CEP350 STOX2 PTPN13 TRPM7 SUPT4H1 PDPK1 TUBB GNAI3 PFKFB4 PDCD4 MAP3K5 | 1.08e-04 | 1118 | 52 | 11 | int:YWHAQ |
| Interaction | TSHR interactions | 1.10e-04 | 96 | 52 | 4 | int:TSHR | |
| Interaction | SHPRH interactions | 1.14e-04 | 97 | 52 | 4 | int:SHPRH | |
| Interaction | TFCP2 interactions | 1.22e-04 | 436 | 52 | 7 | int:TFCP2 | |
| Interaction | IQGAP1 interactions | 1.26e-04 | 591 | 52 | 8 | int:IQGAP1 | |
| Interaction | NME3 interactions | 1.29e-04 | 100 | 52 | 4 | int:NME3 | |
| Interaction | ZMYND8 interactions | 1.31e-04 | 191 | 52 | 5 | int:ZMYND8 | |
| Interaction | GNB1 interactions | 1.34e-04 | 307 | 52 | 6 | int:GNB1 | |
| Interaction | CD48 interactions | 1.39e-04 | 39 | 52 | 3 | int:CD48 | |
| Interaction | BCL11A interactions | 1.39e-04 | 102 | 52 | 4 | int:BCL11A | |
| Interaction | BACC1 interactions | 1.50e-04 | 104 | 52 | 4 | int:BACC1 | |
| Interaction | MBD3L2 interactions | 1.61e-04 | 41 | 52 | 3 | int:MBD3L2 | |
| Interaction | KCNB1 interactions | 1.86e-04 | 43 | 52 | 3 | int:KCNB1 | |
| Interaction | HJURP interactions | 1.92e-04 | 111 | 52 | 4 | int:HJURP | |
| Interaction | LIN9 interactions | 1.92e-04 | 111 | 52 | 4 | int:LIN9 | |
| Interaction | HMGXB4 interactions | 2.06e-04 | 113 | 52 | 4 | int:HMGXB4 | |
| Interaction | ZNF687 interactions | 2.21e-04 | 115 | 52 | 4 | int:ZNF687 | |
| Interaction | YWHAB interactions | CEP350 STOX2 EED PTPN13 TRPM7 PDPK1 TUBB SLAIN1 PFKFB4 MAP3K5 | 2.29e-04 | 1014 | 52 | 10 | int:YWHAB |
| Interaction | KCNV1 interactions | 2.32e-04 | 9 | 52 | 2 | int:KCNV1 | |
| Interaction | KCNG3 interactions | 2.32e-04 | 9 | 52 | 2 | int:KCNG3 | |
| Interaction | RGS18 interactions | 2.32e-04 | 9 | 52 | 2 | int:RGS18 | |
| Interaction | PIK3R4 interactions | 2.43e-04 | 118 | 52 | 4 | int:PIK3R4 | |
| Interaction | CDK2AP1 interactions | 2.43e-04 | 118 | 52 | 4 | int:CDK2AP1 | |
| Interaction | PTK2B interactions | 2.51e-04 | 119 | 52 | 4 | int:PTK2B | |
| Interaction | SUPT6H interactions | 2.54e-04 | 220 | 52 | 5 | int:SUPT6H | |
| Interaction | GATAD2A interactions | 2.76e-04 | 224 | 52 | 5 | int:GATAD2A | |
| Interaction | TUBA1B interactions | 2.76e-04 | 498 | 52 | 7 | int:TUBA1B | |
| Interaction | YWHAE interactions | STOX2 PTPN13 TRPM7 SUPT4H1 PDPK1 TUBB PFKFB4 ARHGAP45 PDCD4 IL7R MAP3K5 | 2.98e-04 | 1256 | 52 | 11 | int:YWHAE |
| Interaction | BRMS1L interactions | 3.03e-04 | 125 | 52 | 4 | int:BRMS1L | |
| Interaction | EPOP interactions | 3.28e-04 | 52 | 52 | 3 | int:EPOP | |
| Interaction | PNO1 interactions | 3.42e-04 | 129 | 52 | 4 | int:PNO1 | |
| Interaction | KRT2 interactions | 3.50e-04 | 236 | 52 | 5 | int:KRT2 | |
| Interaction | TUBB8B interactions | 3.54e-04 | 11 | 52 | 2 | int:TUBB8B | |
| Interaction | FGF2 interactions | 3.87e-04 | 55 | 52 | 3 | int:FGF2 | |
| Interaction | RAD51B interactions | 3.87e-04 | 55 | 52 | 3 | int:RAD51B | |
| Interaction | SAFB interactions | 4.08e-04 | 244 | 52 | 5 | int:SAFB | |
| Interaction | RGS5 interactions | 4.24e-04 | 12 | 52 | 2 | int:RGS5 | |
| Interaction | NR2F2 interactions | 4.54e-04 | 139 | 52 | 4 | int:NR2F2 | |
| Interaction | SUDS3 interactions | 4.79e-04 | 141 | 52 | 4 | int:SUDS3 | |
| Interaction | MX1 interactions | 5.00e-04 | 60 | 52 | 3 | int:MX1 | |
| Interaction | ITLN1 interactions | 5.25e-04 | 61 | 52 | 3 | int:ITLN1 | |
| Interaction | CACNA1C interactions | 5.25e-04 | 61 | 52 | 3 | int:CACNA1C | |
| Interaction | PLCB1 interactions | 5.77e-04 | 63 | 52 | 3 | int:PLCB1 | |
| Interaction | KCNB2 interactions | 6.61e-04 | 66 | 52 | 3 | int:KCNB2 | |
| Interaction | SMARCA5 interactions | 6.72e-04 | 415 | 52 | 6 | int:SMARCA5 | |
| Interaction | HNRNPCL2 interactions | 6.91e-04 | 274 | 52 | 5 | int:HNRNPCL2 | |
| Interaction | KRT18 interactions | 7.07e-04 | 419 | 52 | 6 | int:KRT18 | |
| Interaction | EIF2S1 interactions | 7.14e-04 | 276 | 52 | 5 | int:EIF2S1 | |
| Interaction | CDHR4 interactions | 7.21e-04 | 68 | 52 | 3 | int:CDHR4 | |
| Interaction | SGK3 interactions | 7.53e-04 | 69 | 52 | 3 | int:SGK3 | |
| Interaction | TPR interactions | 7.74e-04 | 281 | 52 | 5 | int:TPR | |
| Interaction | RNF43 interactions | 7.80e-04 | 427 | 52 | 6 | int:RNF43 | |
| Interaction | MBD3L1 interactions | 7.85e-04 | 70 | 52 | 3 | int:MBD3L1 | |
| Interaction | NOC2L interactions | 7.86e-04 | 282 | 52 | 5 | int:NOC2L | |
| Interaction | EPHA7 interactions | 7.86e-04 | 282 | 52 | 5 | int:EPHA7 | |
| Interaction | KRT19 interactions | 7.86e-04 | 282 | 52 | 5 | int:KRT19 | |
| Interaction | MBD2 interactions | 7.88e-04 | 161 | 52 | 4 | int:MBD2 | |
| Interaction | MTA1 interactions | 7.99e-04 | 283 | 52 | 5 | int:MTA1 | |
| Interaction | MYBL2 interactions | 8.07e-04 | 162 | 52 | 4 | int:MYBL2 | |
| Interaction | NGB interactions | 8.25e-04 | 163 | 52 | 4 | int:NGB | |
| Interaction | RBBP5 interactions | 8.51e-04 | 287 | 52 | 5 | int:RBBP5 | |
| Interaction | GNG11 interactions | 8.66e-04 | 17 | 52 | 2 | int:GNG11 | |
| Interaction | RGS16 interactions | 8.66e-04 | 17 | 52 | 2 | int:RGS16 | |
| Cytoband | 22q11.2 | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 IGLV3-16 | 5.83e-20 | 120 | 59 | 12 | 22q11.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 IGLV3-16 | 2.17e-13 | 419 | 59 | 12 | chr22q11 |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV11-55 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 IGLV3-16 | 4.26e-18 | 89 | 47 | 12 | 353 |
| GeneFamily | PHD finger proteins|NuRD complex | 3.56e-06 | 12 | 47 | 3 | 1305 | |
| GeneFamily | PHD finger proteins | 1.65e-03 | 90 | 47 | 3 | 88 | |
| GeneFamily | Tubulins | 2.07e-03 | 26 | 47 | 2 | 778 | |
| GeneFamily | Transient receptor potential cation channels | 2.39e-03 | 28 | 47 | 2 | 249 | |
| GeneFamily | Potassium voltage-gated channels | 4.84e-03 | 40 | 47 | 2 | 274 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.64e-03 | 57 | 47 | 2 | 1179 | |
| Coexpression | MATTIOLI_MGUS_VS_PCL | 3.06e-07 | 127 | 56 | 6 | M10973 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 2.90e-05 | 167 | 56 | 5 | M2995 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP | 3.65e-05 | 87 | 56 | 4 | M18559 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP | 3.94e-05 | 178 | 56 | 5 | M6326 | |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN | 4.16e-05 | 180 | 56 | 5 | M6317 | |
| Coexpression | JIANG_MELANOMA_TRM7_CD8 | 4.16e-05 | 90 | 56 | 4 | M48971 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP | 4.27e-05 | 181 | 56 | 5 | M6323 | |
| Coexpression | GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP | 5.79e-05 | 193 | 56 | 5 | M4177 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP | 6.38e-05 | 197 | 56 | 5 | M5217 | |
| Coexpression | GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN | 6.85e-05 | 200 | 56 | 5 | M8540 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN | 6.85e-05 | 200 | 56 | 5 | M8486 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH1_DN | 6.85e-05 | 200 | 56 | 5 | M5423 | |
| Coexpression | GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP | 6.85e-05 | 200 | 56 | 5 | M6927 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 1.03e-04 | 690 | 56 | 8 | M12224 | |
| Coexpression | CORONEL_RFX7_DIRECT_TARGETS_UP | 1.15e-04 | 44 | 56 | 3 | M42500 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_UP | 1.54e-04 | 126 | 56 | 4 | M16381 | |
| Coexpression | HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP | 1.59e-04 | 49 | 56 | 3 | M41093 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 1.68e-04 | 741 | 56 | 8 | MM1037 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | 1.98e-04 | 567 | 56 | 7 | M16909 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.36e-06 | 339 | 51 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 2.17e-06 | 361 | 51 | 8 | GSM538385_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 3.37e-06 | 383 | 51 | 8 | GSM538403_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | 1.28e-05 | 126 | 51 | 5 | Arv_SC-HD_500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | 2.06e-05 | 139 | 51 | 5 | Arv_SC_fibroblast_500_K3 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3 | 2.27e-05 | 359 | 51 | 7 | GSM538371_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 2.62e-05 | 367 | 51 | 7 | GSM538401_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.67e-05 | 183 | 51 | 5 | Arv_SC_fibroblast_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.67e-05 | 183 | 51 | 5 | Arv_SC-HD_1000_K3 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 1.53e-04 | 338 | 51 | 6 | GSM403987_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.Sp, 4+ 8- 25- 44hi 122lo, Spleen, avg-3 | 1.66e-04 | 343 | 51 | 6 | GSM538365_500 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | IGLV2-8 SCUBE1 IGLV1-44 IGLV1-40 MYO3B APLNR IGLV3-25 MASP2 IGLV3-19 | 1.67e-04 | 848 | 51 | 9 | ratio_ECTO_vs_SC_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.4FP3+25+.Sp, 4+ 8- GFP+ 25+, Spleen, avg-3 | 1.69e-04 | 344 | 51 | 6 | GSM399365_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.LN, TCRb CD44high CD122lo CD4, Lymph Node, avg-3 | 1.80e-04 | 348 | 51 | 6 | GSM538362_500 | |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | 2.12e-04 | 359 | 51 | 6 | GSM404000_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 2.46e-04 | 369 | 51 | 6 | GSM605891_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#2_top-relative-expression-ranked_100 | 2.51e-04 | 10 | 51 | 2 | gudmap_developingKidney_e15.5_Endothelial cells_100_k2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.94e-04 | 244 | 51 | 5 | Arv_SC-H9hpx_1000_K4 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 3.18e-04 | 387 | 51 | 6 | GSM538392_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.50e-04 | 149 | 51 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 4.50e-04 | 149 | 51 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_500 | 5.82e-04 | 15 | 51 | 2 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | 5.99e-04 | 801 | 51 | 8 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | 6.31e-04 | 163 | 51 | 4 | Arv_SC-hpx_blastocyst_500_K2 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | IGLV3-10 IGLV2-8 IGLV1-44 IGLV8-61 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 | 1.56e-11 | 142 | 59 | 8 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f |
| ToppCell | TCGA-Lung|World / Sample_Type by Project: Shred V9 | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV3-27 IL7R IGLV3-25 | 2.43e-11 | 150 | 59 | 8 | 8c133206786e8f22bb70f2a7de9c0cb7f9ea9313 |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | IGLV3-10 STOX2 IGLV1-44 IGLV1-40 IGLV8-61 IGLV4-60 IGLV3-25 IGLV3-19 | 1.09e-10 | 181 | 59 | 8 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 ITGB3 IGLV3-25 IGLV3-19 | 2.06e-10 | 196 | 59 | 8 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV8-61 IGLV3-16 | 2.70e-09 | 169 | 59 | 7 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV1-36 IGLV4-60 IGLV3-16 | 4.02e-09 | 179 | 59 | 7 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV2-8 IGLV1-44 IGLV1-40 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 | 4.18e-09 | 180 | 59 | 7 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV8-61 IGLV3-25 IGLV3-16 | 5.05e-09 | 185 | 59 | 7 | 0fa7970709dc957dea95fabbd83263a0335babd5 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGLV2-8 IGLV1-44 IGLV1-40 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 | 5.05e-09 | 185 | 59 | 7 | 0fff2608f507e019ebb69c27e58fd5be3b049bef |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGLV2-8 IGLV1-44 IGLV1-40 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-19 | 5.05e-09 | 185 | 59 | 7 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV4-60 IGLV3-25 IGLV3-19 | 6.07e-09 | 190 | 59 | 7 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV4-60 IGLV3-25 IGLV3-19 | 6.07e-09 | 190 | 59 | 7 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGLV3-10 IGLV2-8 IGLV1-44 IGLV1-40 IGLV11-55 IGLV3-25 IGLV3-19 | 7.53e-09 | 196 | 59 | 7 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV2-8 IGLV1-44 IGLV1-36 IGLV4-60 IGLV3-27 IGLV3-25 IGLV3-16 | 7.80e-09 | 197 | 59 | 7 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 6.84e-08 | 159 | 59 | 6 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-07 | 173 | 59 | 6 | 0ca2169a275404118038c0489a48062879488765 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-07 | 177 | 59 | 6 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-07 | 177 | 59 | 6 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-3|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.38e-07 | 179 | 59 | 6 | f36776299e570345e18dc38cdef4cfc90e7ed7c2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-07 | 180 | 59 | 6 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-07 | 183 | 59 | 6 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-07 | 184 | 59 | 6 | 15f2c10101ccc8ed059520fc082ee42593dff269 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-07 | 184 | 59 | 6 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 | |
| ToppCell | COVID-19-lung-Plasmablasts|lung / Disease (COVID-19 only), tissue and cell type | 1.73e-07 | 186 | 59 | 6 | 81caf67da9fed09c77b7ddcab9b0b8e4fab2de97 | |
| ToppCell | COVID-19-lung-Plasmablasts|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-07 | 189 | 59 | 6 | fdf6c945b352614885e646a5ef4bc576dee73895 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-07 | 191 | 59 | 6 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-07 | 194 | 59 | 6 | c531c1759a3dfbc85d00ed5eaba35cd14b1b2ac1 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-07 | 194 | 59 | 6 | f902e7eb7e7fbb129c1a6e4160166f16798abaf6 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-07 | 195 | 59 | 6 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.43e-07 | 197 | 59 | 6 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-06 | 143 | 59 | 5 | 57ee1830d96d73d92b5f83b028592a5d952c6013 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 157 | 59 | 5 | cbb08d5c151f0622123276926a2a15bb7d271e90 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 157 | 59 | 5 | 16581e2399a211633f870dce326c75ff4b6a5fe6 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-06 | 169 | 59 | 5 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.08e-06 | 170 | 59 | 5 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.17e-06 | 171 | 59 | 5 | a8adce007ff4c713f71f2359b40cb3575b28c98d | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-06 | 172 | 59 | 5 | f320813177f246926bfd5862b4e0f9bd828cebab | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-06 | 172 | 59 | 5 | b3c12a4bb08ce931de6fe800b605f3e43adea0b5 | |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | 3.26e-06 | 172 | 59 | 5 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 173 | 59 | 5 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 173 | 59 | 5 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 3.55e-06 | 175 | 59 | 5 | d73ee324479172501481b54967a0f3bd870fcf3a | |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.65e-06 | 176 | 59 | 5 | 50e207403d48ce1b55a78897adb5519a2430a626 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 176 | 59 | 5 | 4478b3284201220e902bd2077960dc0d4d4a2c7c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 176 | 59 | 5 | 828ca4d55d726f82f90293c3c7eba081ea3ab92e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-06 | 177 | 59 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.75e-06 | 177 | 59 | 5 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.75e-06 | 177 | 59 | 5 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 177 | 59 | 5 | 36da06ca9577cdb7c7b5114e604f6546b9765c08 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.75e-06 | 177 | 59 | 5 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.75e-06 | 177 | 59 | 5 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.75e-06 | 177 | 59 | 5 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 178 | 59 | 5 | 730720598c530d2a413ef2a3354ecc66ebb4698c | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 178 | 59 | 5 | 8fab75295780e18ee7b4556d66b641c20de10dd2 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 178 | 59 | 5 | cd0c5f15e6b28ce2208346279ee9503d18d9b27d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 178 | 59 | 5 | 813d121a45e0416de1f26862851f6f0bda7ba43c | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 179 | 59 | 5 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 179 | 59 | 5 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-06 | 180 | 59 | 5 | 03e3067ee313e8c40b702b9bc9981f9859d045a2 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.30e-06 | 182 | 59 | 5 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-06 | 183 | 59 | 5 | cf5c98f451a568308c52da5c926543dd4836c6b2 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-06 | 184 | 59 | 5 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-06 | 185 | 59 | 5 | 6ec009e48e50471c28e914c402f500e56a88f8f2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-06 | 185 | 59 | 5 | f49ad6401b2abd089e30eba245b11b5031ea2318 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-06 | 185 | 59 | 5 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-06 | 185 | 59 | 5 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-MALT_B_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.17e-06 | 189 | 59 | 5 | 05e8fb483ebb9010cc54b39d78cca960c58c0f01 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 5.58e-06 | 192 | 59 | 5 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.58e-06 | 192 | 59 | 5 | ca4d8e540d9e6fa47ecf97648cbd5abfc7ab7f85 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.58e-06 | 192 | 59 | 5 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 5.87e-06 | 194 | 59 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.17e-06 | 196 | 59 | 5 | b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.32e-06 | 197 | 59 | 5 | 76465bb2408c7c75f694e8f7cf1a606b796afc3a | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.48e-06 | 198 | 59 | 5 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-06 | 198 | 59 | 5 | 79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-06 | 198 | 59 | 5 | d51ee880acc5804cd918105fac846a1528333d6c | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 160 | 59 | 4 | 5c68d6a76c59e3a7e668ae5471396478a55756ac | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 160 | 59 | 4 | 0fee84844733d36805e1df90ca09478169746708 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 162 | 59 | 4 | 7e6d20704d77b28512690f882f9ddbbd9c5c3228 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 162 | 59 | 4 | 2c193f766f2cefe67682f34325d1de6aed778f49 | |
| ToppCell | droplet-Fat-Scat-18m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 163 | 59 | 4 | b1a38985d0560dbc6ca66f711d52a208303860ca | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-05 | 164 | 59 | 4 | 67c636a2cc32e56c6186dc7e779cc19af04639d2 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-05 | 166 | 59 | 4 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-05 | 166 | 59 | 4 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 166 | 59 | 4 | 33c4876df43b4c1d100699bca47459918bd054d6 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-05 | 168 | 59 | 4 | 2d2eab3190374f79f373e31c8b062ff4e1766396 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-05 | 168 | 59 | 4 | df58156721457b34af1e81c0eb8a7243cbbfb303 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-05 | 168 | 59 | 4 | 68ee3b3b012b56584e313813feb16e632e3f72d2 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 168 | 59 | 4 | 68ef5d1043fca804032669bf990edf110d65cf63 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 169 | 59 | 4 | 81bbdcf1fdf5cad5bfe7a559af196ad0d8e18c35 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 169 | 59 | 4 | b7db33be24a6a9386e277c2f8949551e4d259305 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 170 | 59 | 4 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.61e-05 | 170 | 59 | 4 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.61e-05 | 170 | 59 | 4 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.61e-05 | 170 | 59 | 4 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-05 | 170 | 59 | 4 | 67e78e3c1d4cd3c6eaa5d0a9785b6cd8a3b08039 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 171 | 59 | 4 | 872b3b33cd3893d63c45617db0269692430b0e8b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 171 | 59 | 4 | 8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 171 | 59 | 4 | f4cdd7862c8fe99ee765a2f3ed375b584f4976c5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 7.97e-05 | 172 | 59 | 4 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| Disease | facial paralysis (implicated_via_orthology) | 6.14e-07 | 10 | 52 | 3 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 6.14e-07 | 10 | 52 | 3 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 6.14e-07 | 10 | 52 | 3 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 6.14e-07 | 10 | 52 | 3 | DOID:0112227 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 1.12e-06 | 12 | 52 | 3 | DOID:0050997 (implicated_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 8.47e-05 | 8 | 52 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.71e-04 | 157 | 52 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Amnesia | 4.07e-04 | 17 | 52 | 2 | C0002622 | |
| Disease | Tactile Amnesia | 4.07e-04 | 17 | 52 | 2 | C0750906 | |
| Disease | Amnestic State | 4.07e-04 | 17 | 52 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 4.07e-04 | 17 | 52 | 2 | C0236795 | |
| Disease | Global Amnesia | 4.07e-04 | 17 | 52 | 2 | C0262497 | |
| Disease | Hysterical amnesia | 4.07e-04 | 17 | 52 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 4.07e-04 | 17 | 52 | 2 | C0233796 | |
| Disease | platelet-to-lymphocyte ratio | 4.43e-04 | 363 | 52 | 5 | EFO_0008446 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 5.67e-04 | 20 | 52 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | response to angiotensin receptor blocker | 1.28e-03 | 30 | 52 | 2 | EFO_0010735 | |
| Disease | colorectal cancer (is_implicated_in) | 1.28e-03 | 121 | 52 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | autoimmune thyroid disease | 1.44e-03 | 126 | 52 | 3 | EFO_0006812 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGYETDHQDYCEVCQ | 336 | Q8TDI0 | |
| NFEYDDLAEACYIGD | 11 | P49238 | |
| DDFVYICDDNYQRSE | 1226 | Q8WWL7 | |
| YEEAAAYIQCQFEDL | 296 | P63096 | |
| ESCYDNAEAAFSDDE | 526 | Q68E01 | |
| VQAEDEADYYCLSAD | 96 | A0A075B6K0 | |
| DFDNYYGADNQSECE | 6 | P35414 | |
| LSYGANIEECSEDEY | 151 | Q5JPF3 | |
| VQAEDEADYYCQSAD | 96 | P01717 | |
| GCYNCSQDEYFDHEE | 1176 | Q6W4X9 | |
| ECNSYVYFQGAECEE | 716 | Q92619 | |
| YEEAAAYIQCQFEDL | 296 | P08754 | |
| AQVEDEADYYCYSTD | 96 | A0A075B6K4 | |
| YDYSAADEDEVSFQD | 211 | Q14847 | |
| PNYDDDQENCVYETV | 141 | Q53EL6 | |
| QPEDEADYYCQVYES | 106 | A0A075B6I3 | |
| ECYENSYESLDEDLD | 196 | Q16877 | |
| SGLQSEDEADYYCAA | 96 | P01699 | |
| TCYEVNFDDGSYSDN | 946 | O94953 | |
| QSYVDADADENFYTC | 136 | O75530 | |
| EDAELDDYSFSCYSQ | 31 | P16871 | |
| ENADEYNFVRAYECF | 251 | Q9H422 | |
| RDTNETYDVYCFAEE | 236 | P16112 | |
| EQLQAAYEAGYEQCD | 511 | P16112 | |
| QDEKCDYYFSVDADV | 381 | O00469 | |
| ITGAQADDESDYYCV | 101 | A0A075B6I0 | |
| DCKYDYVEVFDGENE | 81 | O14786 | |
| SEDYEIDQYEEFCFS | 356 | P36888 | |
| EVCDDYSLDDNEYFF | 71 | Q14721 | |
| VCDDYNLNENEYFFD | 76 | Q92953 | |
| ASAIAQDADQNYDYA | 231 | Q7Z5L3 | |
| VDGYETDHQDYCEVC | 371 | Q12873 | |
| INEDEDCYSDERYQC | 2576 | Q5VT06 | |
| EAFYAAEDIDECQVA | 131 | O00187 | |
| EDDCVVRFQYYEDSS | 686 | P05106 | |
| AVDGYETDHQDYCEV | 361 | Q14839 | |
| QCEDIDECENDYYNG | 71 | Q8IWY4 | |
| YDACAQVEIDEYQNY | 1286 | Q96RY7 | |
| GEQEYFSSEECYEDD | 1841 | Q01668 | |
| SYIQEDDIYDDSQEA | 2041 | Q12923 | |
| CESDLLEYDYEYDEN | 666 | Q99683 | |
| SGLQSEDEADYYCAA | 96 | A0A0B4J1U3 | |
| AEDEADYYCQSYDSS | 101 | P01703 | |
| AQVEDEADYYCYSAA | 96 | P01718 | |
| AQAEDEADYYCNSRD | 96 | P01714 | |
| VSGLQAEDEADYYCS | 96 | P01709 | |
| SNLQFEDEADYYCET | 101 | A0A075B6I1 | |
| SEDDEDCYGNYDNLL | 366 | O15530 | |
| GTCSDQEYDQYSLED | 311 | Q8ND83 | |
| DQFEYDGCDNCDAYL | 26 | P63272 | |
| SYNAETEDCDLNYSD | 1091 | O60673 | |
| EYQQYQDATAEEEED | 421 | Q3ZCM7 | |
| NQEASFDYYNVSDDD | 766 | Q9P2F5 | |
| EYQQYQDATAEEEED | 421 | A6NNZ2 | |
| EYQQYQDATAEEEED | 421 | P07437 | |
| CDTYATEFDLEAEEY | 206 | Q9Y265 | |
| ELENDYCLNDYNISE | 76 | Q86XD8 | |
| GEVYAYEIDVCANDS | 1046 | Q96QT4 | |
| CEQELQDDDFYAYDE | 126 | Q13507 | |
| EVIACEQQYDSSYDA | 201 | Q8WXR4 |